BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang LH, Wang Y, Fan QQ, Liu YK, Li LH, Qi XW, Mao Y, Hua D. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. World J Gastroenterol 2019; 25(38): 5814-5825 [PMID: 31636474 DOI: 10.3748/wjg.v25.i38.5814]
URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5814.htm
Number Citing Articles
1
La-Mei Chen, Lin Xiang, Wei-Juan Sun, Yu-Jia Zhai, Shuai Gao, Yu-Chen Fan, Kai Wang. Diagnostic Value of the Hypomethylation of the <i>WISP1</i> Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B VirusThe Tohoku Journal of Experimental Medicine 2020; 252(4): 297 doi: 10.1620/tjem.252.297
2
Moza Mohamed Al-Ali, Amir Ali Khan, Abeer Maher Fayyad, Sallam Hasan Abdallah, Muhammad Nasir Khan Khattak. Transcriptomic profiling of the telomerase transformed Mesenchymal stromal cells derived adipocytes in response to rosiglitazoneBMC Genomic Data 2022; 23(1) doi: 10.1186/s12863-022-01027-z
3
Herman Yeger, Bernard Perbal. The CCN axis in cancer development and progressionJournal of Cell Communication and Signaling 2021; 15(4): 491 doi: 10.1007/s12079-021-00618-2
4
Yanqiong Liu, Weijuan Qin, Fuyong Zhang, Jian Wang, Xi Li, Shan Li, Xue Qin, Yuefeng Lu. Association between WNT-1-inducible signaling pathway protein-1 (WISP1) genetic polymorphisms and the risk of gastric cancer in Guangxi ChineseCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02116-2
5
Xinxin Lu, Runzhou Li, Xingshuang Wang, Qixuan Guo, Ling Wang, Xin Zhou. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient PrognosisCancer Biotherapy and Radiopharmaceuticals 2021;  doi: 10.1089/cbr.2021.0215
6
Lihua Zhang, Xin Jiang, Yan Li, Qianqian Fan, Hongjuan Li, Linfang Jin, Liqi Li, Yufen Jin, Ting Zhang, Yong Mao, Dong Hua. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma PrognosisFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01504